Abstract Purpose: To reduce the high recurrence rate of nephrolithiasis, patients are routinely prescribed secondary chemoprevention therapy with alkali citrate (AlkasolveĀ®; Sam-On Ltd) for uric acid stones and hypocitraturia or hydrochlorthiazide (DisothiazideĀ®; Dexcel Ltd) for hypercalciuria. However, data on adherence to these regimens are limited. The aim of this study was to...